ReviewFuture science OA2019

Checkpoint inhibitors plus chemotherapy for first-line treatment of advanced non-small cell lung cancer: a systematic review and meta-analysis of randomized controlled trials.

Aung Myint Tun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.